Bavarian Nordic eyes more U.S. government contracts after new vaccine order

Share this post

COPENHAGEN (Reuters) – Danish drug maker Bavarian Nordic expects to win further U.S. contracts for its smallpox vaccine after it secured a key government order, the company said on Thursday.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply